CINCINNATI and SEOUL, South Korea, Jan. 31, 2023 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, and ...
There's no foolproof way to know the future for Meridian Bioscience (NASDAQ: VIVO) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before ...
MONHEIM AM RHEIN, Germany--(BUSINESS WIRE)--Resolve Biosciences, the pioneer in Molecular Cartography™ technology, today announced the expansion of its end-to-end Meridian service offering for spatial ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Meridian Bioscience has made ...
CINCINNATI, July 29, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (VIVO) (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced that it ...
CINCINNATI, April 23, 2025 /PRNewswire/ -- The Life Science division of Meridian Bioscience, Inc., a leading global manufacturer of diagnostics and life science raw materials, today announced the ...
(Reuters) - The U.S. Food and Drug Administration approved on Friday the first test - a diagnostic from Meridian Bioscience Inc - to help detect a type of herpes virus in newborns. Meridian's Alethia ...
Meridian Bioscience subsidiary Magellan Diagnostics was previously ordered to pay $42 million for selling the tests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results